| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatoblastoma | 9 | 2023 | 87 | 2.260 |
Why?
|
| Gastrointestinal Stromal Tumors | 4 | 2016 | 646 | 1.090 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2016 | 991 | 0.880 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 2022 | 740 | 0.880 |
Why?
|
| Bupivacaine | 2 | 2018 | 411 | 0.840 |
Why?
|
| Peritoneal Dialysis | 2 | 2013 | 147 | 0.820 |
Why?
|
| Intestinal Obstruction | 3 | 2023 | 424 | 0.820 |
Why?
|
| Aptamers, Nucleotide | 1 | 2023 | 166 | 0.810 |
Why?
|
| Liver Neoplasms | 10 | 2023 | 4251 | 0.790 |
Why?
|
| Splenectomy | 3 | 2020 | 394 | 0.740 |
Why?
|
| Ovariectomy | 3 | 2019 | 661 | 0.720 |
Why?
|
| Child | 64 | 2023 | 77637 | 0.680 |
Why?
|
| Anesthetics, Local | 2 | 2018 | 985 | 0.660 |
Why?
|
| Ovarian Neoplasms | 5 | 2021 | 4839 | 0.650 |
Why?
|
| Rectal Diseases | 1 | 2019 | 143 | 0.620 |
Why?
|
| Myasthenia Gravis | 2 | 2017 | 199 | 0.590 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 2217 | 0.590 |
Why?
|
| Certification | 1 | 2020 | 423 | 0.580 |
Why?
|
| Neoplasms, Second Primary | 2 | 2019 | 1063 | 0.580 |
Why?
|
| Thymectomy | 1 | 2017 | 191 | 0.560 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 2021 | 162 | 0.520 |
Why?
|
| Liposomes | 1 | 2018 | 759 | 0.510 |
Why?
|
| Preoperative Care | 5 | 2019 | 2251 | 0.470 |
Why?
|
| Child, Preschool | 36 | 2021 | 40964 | 0.430 |
Why?
|
| Hernia, Inguinal | 3 | 2021 | 209 | 0.420 |
Why?
|
| Renal Insufficiency | 2 | 2021 | 805 | 0.420 |
Why?
|
| Rectum | 2 | 2009 | 904 | 0.420 |
Why?
|
| Infant | 31 | 2022 | 35122 | 0.420 |
Why?
|
| Gastrectomy | 1 | 2016 | 663 | 0.410 |
Why?
|
| Pediatrics | 4 | 2020 | 3474 | 0.410 |
Why?
|
| Survivors | 4 | 2023 | 2291 | 0.410 |
Why?
|
| Spleen | 1 | 2018 | 2359 | 0.410 |
Why?
|
| Catheters, Indwelling | 2 | 2021 | 427 | 0.400 |
Why?
|
| Catheterization | 2 | 2016 | 1469 | 0.400 |
Why?
|
| General Surgery | 2 | 2014 | 1636 | 0.390 |
Why?
|
| Polyglycolic Acid | 1 | 2012 | 406 | 0.380 |
Why?
|
| Bone Neoplasms | 1 | 2023 | 2529 | 0.380 |
Why?
|
| Adolescent | 36 | 2022 | 85729 | 0.370 |
Why?
|
| Pancreatic Neoplasms | 4 | 2021 | 5264 | 0.360 |
Why?
|
| Rectovaginal Fistula | 1 | 2009 | 11 | 0.360 |
Why?
|
| Analgesia | 1 | 2014 | 461 | 0.360 |
Why?
|
| Sutures | 1 | 2012 | 299 | 0.360 |
Why?
|
| Neoplasms | 9 | 2023 | 21675 | 0.350 |
Why?
|
| Intestinal Atresia | 1 | 2009 | 68 | 0.350 |
Why?
|
| Pylorus | 1 | 2009 | 86 | 0.340 |
Why?
|
| Situs Inversus | 1 | 2009 | 64 | 0.340 |
Why?
|
| Tibial Arteries | 1 | 2009 | 57 | 0.330 |
Why?
|
| Femoral Neoplasms | 1 | 2009 | 77 | 0.330 |
Why?
|
| Urinary Bladder Diseases | 1 | 2009 | 166 | 0.330 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2008 | 32 | 0.330 |
Why?
|
| Splenic Diseases | 2 | 2020 | 94 | 0.330 |
Why?
|
| Pulmonary Blastoma | 1 | 2008 | 33 | 0.320 |
Why?
|
| Mesentery | 1 | 2009 | 205 | 0.320 |
Why?
|
| Intestinal Volvulus | 1 | 2009 | 65 | 0.320 |
Why?
|
| Self Report | 1 | 2019 | 3550 | 0.320 |
Why?
|
| Neuroblastoma | 2 | 2023 | 1226 | 0.310 |
Why?
|
| Retrospective Studies | 31 | 2023 | 77410 | 0.310 |
Why?
|
| Infant, Newborn | 20 | 2021 | 25609 | 0.310 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2013 | 3537 | 0.310 |
Why?
|
| Nanomedicine | 1 | 2011 | 302 | 0.310 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 1534 | 0.310 |
Why?
|
| Humans | 105 | 2023 | 743811 | 0.310 |
Why?
|
| Abnormalities, Multiple | 3 | 2009 | 1416 | 0.310 |
Why?
|
| Choristoma | 1 | 2009 | 213 | 0.310 |
Why?
|
| Critical Care | 1 | 2020 | 2647 | 0.310 |
Why?
|
| Tumor Necrosis Factor-alpha | 11 | 2010 | 4422 | 0.300 |
Why?
|
| Diseases in Twins | 1 | 2009 | 450 | 0.300 |
Why?
|
| Lactic Acid | 1 | 2012 | 1131 | 0.290 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2023 | 11524 | 0.290 |
Why?
|
| Ureter | 1 | 2009 | 375 | 0.290 |
Why?
|
| Anal Canal | 1 | 2009 | 376 | 0.280 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 1161 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2008 | 5170 | 0.280 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2022 | 1363 | 0.270 |
Why?
|
| Apoptosis | 10 | 2005 | 9718 | 0.270 |
Why?
|
| Saphenous Vein | 1 | 2009 | 532 | 0.270 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2009 | 277 | 0.270 |
Why?
|
| Cause of Death | 2 | 2018 | 3580 | 0.260 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2265 | 0.260 |
Why?
|
| Breast Neoplasms | 12 | 2010 | 20827 | 0.260 |
Why?
|
| Neoplasm Staging | 6 | 2021 | 11036 | 0.250 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 604 | 0.250 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 697 | 0.250 |
Why?
|
| Liver Transplantation | 3 | 2023 | 2119 | 0.240 |
Why?
|
| Female | 55 | 2023 | 380020 | 0.240 |
Why?
|
| Vagina | 1 | 2009 | 825 | 0.240 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4245 | 0.240 |
Why?
|
| Cell Survival | 8 | 2010 | 5881 | 0.240 |
Why?
|
| Vincristine | 5 | 2023 | 1039 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2019 | 5445 | 0.230 |
Why?
|
| Prenatal Diagnosis | 2 | 2012 | 1237 | 0.230 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2005 | 334 | 0.220 |
Why?
|
| Osteosarcoma | 1 | 2009 | 881 | 0.220 |
Why?
|
| Pleural Neoplasms | 1 | 2008 | 608 | 0.220 |
Why?
|
| Male | 48 | 2023 | 349776 | 0.220 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 665 | 0.220 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2022 | 3480 | 0.210 |
Why?
|
| Intestine, Small | 1 | 2009 | 1240 | 0.210 |
Why?
|
| Protein Kinase C | 2 | 2005 | 1227 | 0.210 |
Why?
|
| Sodium Channel Blockers | 1 | 2023 | 176 | 0.210 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 13112 | 0.210 |
Why?
|
| Tetrodotoxin | 1 | 2023 | 259 | 0.210 |
Why?
|
| Estrogen Receptor alpha | 4 | 2012 | 577 | 0.210 |
Why?
|
| Incidence | 10 | 2021 | 20948 | 0.210 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 501 | 0.200 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2002 | 70 | 0.200 |
Why?
|
| Referral and Consultation | 1 | 2014 | 3530 | 0.200 |
Why?
|
| Postoperative Complications | 6 | 2021 | 15281 | 0.200 |
Why?
|
| Piperazines | 1 | 2012 | 2487 | 0.200 |
Why?
|
| Hernia, Femoral | 1 | 2021 | 17 | 0.190 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3679 | 0.190 |
Why?
|
| Young Adult | 13 | 2023 | 56392 | 0.190 |
Why?
|
| Appendectomy | 2 | 2020 | 401 | 0.190 |
Why?
|
| Paraganglioma | 1 | 2022 | 143 | 0.190 |
Why?
|
| Organic Chemicals | 1 | 2001 | 210 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 2217 | 0.180 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2021 | 88 | 0.180 |
Why?
|
| Tumor Cells, Cultured | 9 | 2005 | 6311 | 0.180 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1968 | 0.180 |
Why?
|
| Wilms Tumor | 1 | 2023 | 373 | 0.180 |
Why?
|
| Intestines | 1 | 2009 | 1923 | 0.180 |
Why?
|
| Pheochromocytoma | 1 | 2022 | 337 | 0.180 |
Why?
|
| Hernia, Umbilical | 1 | 2021 | 96 | 0.180 |
Why?
|
| Pyrimidines | 1 | 2012 | 2945 | 0.180 |
Why?
|
| Prognosis | 12 | 2022 | 29052 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2005 | 638 | 0.170 |
Why?
|
| Delayed-Action Preparations | 1 | 2023 | 967 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 646 | 0.170 |
Why?
|
| Estrogens | 3 | 2010 | 1563 | 0.170 |
Why?
|
| Chronic Disease | 4 | 2023 | 9139 | 0.170 |
Why?
|
| Follow-Up Studies | 11 | 2022 | 39001 | 0.170 |
Why?
|
| Pain | 1 | 2014 | 4987 | 0.170 |
Why?
|
| Gallbladder Diseases | 1 | 2020 | 125 | 0.170 |
Why?
|
| Flavones | 2 | 2012 | 66 | 0.170 |
Why?
|
| Sulfones | 1 | 2001 | 434 | 0.160 |
Why?
|
| NF-kappa B | 3 | 2004 | 2500 | 0.160 |
Why?
|
| Biopsy | 6 | 2020 | 6750 | 0.160 |
Why?
|
| Hernia, Ventral | 1 | 2021 | 176 | 0.160 |
Why?
|
| Teratoma | 1 | 2021 | 393 | 0.160 |
Why?
|
| End Stage Liver Disease | 1 | 2022 | 314 | 0.160 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2019 | 68 | 0.160 |
Why?
|
| Cholecystectomy | 1 | 2020 | 395 | 0.160 |
Why?
|
| Resource Allocation | 1 | 2020 | 341 | 0.160 |
Why?
|
| Testicular Diseases | 1 | 2018 | 71 | 0.160 |
Why?
|
| Micelles | 1 | 2018 | 203 | 0.150 |
Why?
|
| Epoprostenol | 1 | 2018 | 254 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2016 | 379 | 0.150 |
Why?
|
| Risk Factors | 11 | 2023 | 72252 | 0.150 |
Why?
|
| Laparoscopy | 2 | 2020 | 2148 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 9239 | 0.150 |
Why?
|
| Anesthetics | 1 | 2023 | 539 | 0.150 |
Why?
|
| Catheterization, Central Venous | 1 | 2021 | 514 | 0.140 |
Why?
|
| United States | 13 | 2022 | 69859 | 0.140 |
Why?
|
| Electron Transport Complex II | 1 | 2016 | 48 | 0.140 |
Why?
|
| Cisplatin | 4 | 2021 | 1662 | 0.140 |
Why?
|
| Colon | 1 | 2005 | 1772 | 0.140 |
Why?
|
| Glomus Tumor | 1 | 2017 | 66 | 0.140 |
Why?
|
| MAP Kinase Kinase 5 | 2 | 2008 | 10 | 0.140 |
Why?
|
| Nitriles | 1 | 2001 | 953 | 0.140 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 1422 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1400 | 0.140 |
Why?
|
| Survival Analysis | 4 | 2013 | 10251 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2012 | 5532 | 0.140 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3769 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2008 | 66 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2016 | 780 | 0.130 |
Why?
|
| Succinate Dehydrogenase | 1 | 2016 | 146 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2006 | 37 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2020 | 694 | 0.130 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 409 | 0.130 |
Why?
|
| Heart Arrest | 2 | 2022 | 1470 | 0.130 |
Why?
|
| Lung Diseases | 2 | 2019 | 1887 | 0.130 |
Why?
|
| Ascitic Fluid | 1 | 2015 | 192 | 0.130 |
Why?
|
| Societies, Medical | 2 | 2019 | 3740 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 582 | 0.130 |
Why?
|
| Disease-Free Survival | 4 | 2019 | 6895 | 0.130 |
Why?
|
| Critical Illness | 2 | 2020 | 2670 | 0.130 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 139 | 0.130 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1100 | 0.130 |
Why?
|
| Siblings | 1 | 2019 | 853 | 0.130 |
Why?
|
| Treatment Outcome | 13 | 2023 | 63042 | 0.120 |
Why?
|
| Fluorouracil | 3 | 2017 | 1619 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 8300 | 0.120 |
Why?
|
| Adult | 15 | 2023 | 213889 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2004 | 2927 | 0.120 |
Why?
|
| Hospital Charges | 1 | 2016 | 362 | 0.120 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 2016 | 220 | 0.120 |
Why?
|
| Etoposide | 2 | 2008 | 641 | 0.120 |
Why?
|
| Ascites | 1 | 2016 | 344 | 0.120 |
Why?
|
| Combined Modality Therapy | 3 | 2012 | 8637 | 0.120 |
Why?
|
| Teaching | 1 | 2002 | 1173 | 0.120 |
Why?
|
| Phorbol Esters | 2 | 2005 | 111 | 0.120 |
Why?
|
| Estrogen Receptor Modulators | 2 | 2012 | 60 | 0.120 |
Why?
|
| Heart Defects, Congenital | 4 | 2009 | 4584 | 0.110 |
Why?
|
| Plasmapheresis | 1 | 2014 | 211 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6539 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 2016 | 337 | 0.110 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2047 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 781 | 0.110 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2015 | 324 | 0.110 |
Why?
|
| Wounds and Injuries | 2 | 2003 | 2401 | 0.110 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 12954 | 0.110 |
Why?
|
| Chalcone | 1 | 2012 | 10 | 0.110 |
Why?
|
| Academies and Institutes | 1 | 2015 | 317 | 0.110 |
Why?
|
| Physicians | 1 | 2011 | 4569 | 0.110 |
Why?
|
| Survival Rate | 3 | 2019 | 12786 | 0.110 |
Why?
|
| Hepatectomy | 2 | 2022 | 550 | 0.100 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2004 | 197 | 0.100 |
Why?
|
| Skin | 2 | 2019 | 4372 | 0.100 |
Why?
|
| Luciferases | 3 | 2004 | 733 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2020 | 3308 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1520 | 0.100 |
Why?
|
| Cytodiagnosis | 1 | 2015 | 435 | 0.100 |
Why?
|
| Databases, Factual | 2 | 2019 | 7729 | 0.100 |
Why?
|
| Kidney Neoplasms | 2 | 2023 | 4260 | 0.100 |
Why?
|
| Device Removal | 1 | 2016 | 655 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1636 | 0.100 |
Why?
|
| Doxorubicin | 4 | 2021 | 2234 | 0.090 |
Why?
|
| Drainage | 1 | 2016 | 1142 | 0.090 |
Why?
|
| Sarcoma | 1 | 2022 | 1898 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1642 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2010 | 2938 | 0.090 |
Why?
|
| Sickle Cell Trait | 1 | 2010 | 81 | 0.090 |
Why?
|
| Signal Transduction | 8 | 2010 | 23398 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 452 | 0.090 |
Why?
|
| Aftercare | 1 | 2016 | 870 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2015 | 763 | 0.090 |
Why?
|
| Cyclophosphamide | 2 | 2008 | 2241 | 0.090 |
Why?
|
| Anesthesia, Local | 1 | 2012 | 275 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2016 | 2634 | 0.090 |
Why?
|
| Polyhydramnios | 1 | 2009 | 41 | 0.090 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2009 | 35 | 0.090 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2009 | 59 | 0.090 |
Why?
|
| Gynecomastia | 1 | 2010 | 87 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 12354 | 0.090 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 652 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2002 | 623 | 0.090 |
Why?
|
| Rats | 2 | 2018 | 24250 | 0.080 |
Why?
|
| Mesna | 1 | 2008 | 66 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 3503 | 0.080 |
Why?
|
| Tamoxifen | 2 | 2004 | 981 | 0.080 |
Why?
|
| Age Factors | 4 | 2018 | 18355 | 0.080 |
Why?
|
| Ifosfamide | 1 | 2008 | 228 | 0.080 |
Why?
|
| Sarcoma, Synovial | 1 | 2009 | 167 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12243 | 0.080 |
Why?
|
| Liver Failure, Acute | 1 | 2009 | 165 | 0.080 |
Why?
|
| Logistic Models | 2 | 2013 | 13404 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2004 | 1157 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 1877 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 2 | 2008 | 2764 | 0.080 |
Why?
|
| Time Factors | 6 | 2020 | 40038 | 0.070 |
Why?
|
| Curriculum | 1 | 2020 | 3603 | 0.070 |
Why?
|
| Estrogen Receptor beta | 2 | 2006 | 175 | 0.070 |
Why?
|
| Lung | 2 | 2019 | 9858 | 0.070 |
Why?
|
| Melphalan | 1 | 2008 | 431 | 0.070 |
Why?
|
| Pneumonectomy | 2 | 2017 | 1098 | 0.070 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 1775 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 1434 | 0.070 |
Why?
|
| Tissue Donors | 2 | 2022 | 2241 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2002 | 3524 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 7172 | 0.070 |
Why?
|
| Benzamides | 1 | 2012 | 1383 | 0.070 |
Why?
|
| Prevalence | 2 | 2021 | 15211 | 0.070 |
Why?
|
| Genetic Counseling | 1 | 2009 | 600 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 648 | 0.070 |
Why?
|
| Nanostructures | 1 | 2011 | 552 | 0.070 |
Why?
|
| Mesoderm | 1 | 2008 | 686 | 0.070 |
Why?
|
| Carboplatin | 1 | 2008 | 801 | 0.070 |
Why?
|
| Apigenin | 1 | 2005 | 14 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 693 | 0.070 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 1179 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2009 | 341 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2004 | 42 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2004 | 53 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2010 | 2298 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 1 | 2009 | 848 | 0.060 |
Why?
|
| Morbidity | 1 | 2010 | 1768 | 0.060 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 547 | 0.060 |
Why?
|
| Transcription, Genetic | 4 | 2010 | 7719 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2020 | 40545 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2004 | 12209 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3677 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3750 | 0.060 |
Why?
|
| Receptors, Estrogen | 2 | 2004 | 2190 | 0.060 |
Why?
|
| Age Distribution | 1 | 2010 | 2899 | 0.060 |
Why?
|
| Sepsis | 1 | 2018 | 2593 | 0.060 |
Why?
|
| Cathartics | 1 | 2005 | 125 | 0.060 |
Why?
|
| Epithelium | 1 | 2008 | 1679 | 0.060 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 576 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2023 | 53250 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2008 | 689 | 0.060 |
Why?
|
| Neuroendocrine Tumors | 1 | 2009 | 594 | 0.060 |
Why?
|
| Therapeutic Irrigation | 1 | 2005 | 300 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2022 | 20121 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 2504 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 1770 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2004 | 234 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 35409 | 0.060 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 2002 | 40 | 0.060 |
Why?
|
| Boston | 1 | 2016 | 9310 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3617 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2002 | 3917 | 0.060 |
Why?
|
| Hypertension | 1 | 2023 | 8480 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2736 | 0.050 |
Why?
|
| Response Elements | 1 | 2004 | 312 | 0.050 |
Why?
|
| Syndrome | 1 | 2009 | 3249 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2023 | 223 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2009 | 2280 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 335 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 13691 | 0.050 |
Why?
|
| Louisiana | 1 | 2002 | 108 | 0.050 |
Why?
|
| Catecholamines | 1 | 2023 | 387 | 0.050 |
Why?
|
| Estradiol | 3 | 2012 | 2017 | 0.050 |
Why?
|
| Flavonoids | 1 | 2005 | 443 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2013 | 5316 | 0.050 |
Why?
|
| Quality of Life | 2 | 2022 | 12788 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5136 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2009 | 1695 | 0.050 |
Why?
|
| Mitotane | 1 | 2021 | 18 | 0.050 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2022 | 116 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 880 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 2453 | 0.050 |
Why?
|
| Organizational Case Studies | 1 | 2002 | 299 | 0.050 |
Why?
|
| Wound Healing | 1 | 2012 | 2776 | 0.050 |
Why?
|
| Gestational Age | 1 | 2009 | 3488 | 0.050 |
Why?
|
| Resuscitation Orders | 1 | 2003 | 269 | 0.050 |
Why?
|
| Carcinosarcoma | 1 | 2001 | 108 | 0.050 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2020 | 26 | 0.050 |
Why?
|
| Groin | 1 | 2021 | 105 | 0.050 |
Why?
|
| Reoperation | 2 | 2009 | 4200 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 461 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2004 | 3701 | 0.050 |
Why?
|
| Melanoma | 1 | 2019 | 5508 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 1284 | 0.050 |
Why?
|
| Pancreatectomy | 2 | 2021 | 804 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 749 | 0.040 |
Why?
|
| Carcinogens | 1 | 2002 | 466 | 0.040 |
Why?
|
| Disease Progression | 1 | 2016 | 13273 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 2002 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2012 | 9848 | 0.040 |
Why?
|
| Cell Line, Tumor | 5 | 2012 | 16674 | 0.040 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2000 | 91 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
| Abdominal Wall | 1 | 2021 | 157 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5691 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2009 | 1195 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7880 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15526 | 0.040 |
Why?
|
| Proteomics | 2 | 2010 | 3639 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 13980 | 0.040 |
Why?
|
| Adrenalectomy | 1 | 2021 | 342 | 0.040 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2001 | 413 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7270 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1637 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 2004 | 783 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 23327 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 213241 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2022 | 2034 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2002 | 1851 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4033 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11360 | 0.040 |
Why?
|
| International Agencies | 1 | 2018 | 240 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1545 | 0.040 |
Why?
|
| Paclitaxel | 2 | 2001 | 1705 | 0.040 |
Why?
|
| Cell Division | 1 | 2004 | 4568 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4561 | 0.040 |
Why?
|
| North America | 1 | 2020 | 1249 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2006 | 8436 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2021 | 552 | 0.030 |
Why?
|
| Constipation | 1 | 2020 | 546 | 0.030 |
Why?
|
| Methotrexate | 1 | 2002 | 1726 | 0.030 |
Why?
|
| Ceramides | 3 | 2003 | 199 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 3142 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2003 | 980 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2021 | 1262 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10259 | 0.030 |
Why?
|
| Pyridostigmine Bromide | 1 | 2014 | 31 | 0.030 |
Why?
|
| Pathology, Surgical | 1 | 2015 | 155 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2019 | 710 | 0.030 |
Why?
|
| Camptothecin | 1 | 2017 | 576 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2022 | 1158 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 1385 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 13869 | 0.030 |
Why?
|
| Animals | 3 | 2018 | 168660 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2019 | 560 | 0.030 |
Why?
|
| Pregnancy | 3 | 2012 | 29140 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 2016 | 0.030 |
Why?
|
| Atrophy | 1 | 2018 | 1577 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3794 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2064 | 0.030 |
Why?
|
| Scoliosis | 1 | 2019 | 725 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1996 | 687 | 0.030 |
Why?
|
| Transfection | 3 | 2010 | 5892 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2002 | 1352 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 29777 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 2647 | 0.030 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 7658 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 3268 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5078 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9272 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2018 | 1533 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2001 | 1585 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 1917 | 0.020 |
Why?
|
| Vinculin | 1 | 2010 | 62 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 2010 | 182 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2019 | 1241 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 9440 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 1996 | 2375 | 0.020 |
Why?
|
| Operating Rooms | 1 | 2016 | 817 | 0.020 |
Why?
|
| Delayed Graft Function | 1 | 2009 | 48 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3476 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 4931 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2008 | 118 | 0.020 |
Why?
|
| Factor XIII | 1 | 1989 | 59 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 25032 | 0.020 |
Why?
|
| Aprotinin | 1 | 1989 | 88 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 278 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1996 | 1656 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 1989 | 128 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 1787 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7793 | 0.020 |
Why?
|
| Hemochromatosis | 1 | 2009 | 184 | 0.020 |
Why?
|
| Sternum | 1 | 1989 | 177 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10477 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4749 | 0.020 |
Why?
|
| Length of Stay | 2 | 2019 | 6311 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2008 | 5179 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4552 | 0.020 |
Why?
|
| Tissue Adhesives | 1 | 1989 | 179 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3503 | 0.020 |
Why?
|
| Diet | 1 | 2005 | 7930 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17439 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2006 | 25 | 0.020 |
Why?
|
| Thrombin | 1 | 1989 | 598 | 0.020 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 1209 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8337 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6237 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3117 | 0.020 |
Why?
|
| Fibrinogen | 1 | 1989 | 894 | 0.020 |
Why?
|
| Health Status | 1 | 2018 | 4031 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 975 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 2241 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2503 | 0.020 |
Why?
|
| Kidney | 1 | 2019 | 7185 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5388 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2010 | 1660 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4204 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 1581 | 0.010 |
Why?
|
| Benchmarking | 1 | 2009 | 1042 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 1156 | 0.010 |
Why?
|
| Electrocardiography | 2 | 2003 | 6441 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2016 | 4286 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 7908 | 0.010 |
Why?
|
| Glycine-tRNA Ligase | 1 | 2001 | 2 | 0.010 |
Why?
|
| Receptors, Laminin | 1 | 2001 | 26 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2001 | 40 | 0.010 |
Why?
|
| Transportation of Patients | 1 | 2003 | 185 | 0.010 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2001 | 40 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 122 | 0.010 |
Why?
|
| Tissue and Organ Procurement | 1 | 2009 | 896 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2003 | 363 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4221 | 0.010 |
Why?
|
| Birth Weight | 1 | 2009 | 2069 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1996 | 6622 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2008 | 13028 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 494 | 0.010 |
Why?
|
| Imidazoles | 1 | 2006 | 1206 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 3504 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2001 | 430 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2000 | 821 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1639 | 0.010 |
Why?
|
| Cell Death | 1 | 2003 | 1705 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 690 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 18107 | 0.010 |
Why?
|
| Fibronectins | 1 | 2001 | 726 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2000 | 625 | 0.010 |
Why?
|
| Esophagectomy | 1 | 2001 | 447 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4463 | 0.010 |
Why?
|
| Pancreas | 1 | 2004 | 1686 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2010 | 5021 | 0.010 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1996 | 35 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 1460 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 2891 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1998 | 595 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 163178 | 0.010 |
Why?
|
| Caspases | 1 | 1998 | 928 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1729 | 0.010 |
Why?
|
| Esophagus | 1 | 2001 | 1019 | 0.010 |
Why?
|
| Plasmids | 1 | 2000 | 2308 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 8430 | 0.010 |
Why?
|
| Pulmonary Veins | 2 | 1988 | 761 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2000 | 878 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 2827 | 0.010 |
Why?
|
| Injections | 1 | 1996 | 839 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19894 | 0.010 |
Why?
|
| Auditory Cortex | 1 | 1996 | 345 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 12718 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1988 | 8939 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1996 | 832 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 16361 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6620 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1996 | 1395 | 0.010 |
Why?
|
| Venae Cavae | 1 | 1988 | 41 | 0.010 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 1989 | 85 | 0.010 |
Why?
|
| Visual Cortex | 1 | 1996 | 1136 | 0.000 |
Why?
|
| Obesity | 1 | 2010 | 12744 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 10940 | 0.000 |
Why?
|
| Models, Biological | 1 | 2003 | 9582 | 0.000 |
Why?
|
| Cell Line | 1 | 2000 | 15993 | 0.000 |
Why?
|
| Neural Pathways | 1 | 1996 | 2971 | 0.000 |
Why?
|
| Random Allocation | 1 | 1989 | 2429 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1989 | 1958 | 0.000 |
Why?
|
| Heart Valve Prosthesis | 1 | 1972 | 1489 | 0.000 |
Why?
|
| Hepatitis B | 1 | 1989 | 693 | 0.000 |
Why?
|
| HIV Seropositivity | 1 | 1989 | 971 | 0.000 |
Why?
|
| Angiocardiography | 2 | 1972 | 162 | 0.000 |
Why?
|
| Emergencies | 1 | 1989 | 1170 | 0.000 |
Why?
|
| Aorta | 1 | 1988 | 2062 | 0.000 |
Why?
|
| Pulmonary Artery | 1 | 1988 | 1911 | 0.000 |
Why?
|
| Hepatitis C | 1 | 1989 | 1591 | 0.000 |
Why?
|
| Myocardium | 1 | 1988 | 4775 | 0.000 |
Why?
|
| Extracorporeal Circulation | 1 | 1972 | 182 | 0.000 |
Why?
|
| Tricuspid Valve | 1 | 1972 | 403 | 0.000 |
Why?
|
| Pulmonary Circulation | 1 | 1972 | 739 | 0.000 |
Why?
|
| Thromboembolism | 1 | 1972 | 987 | 0.000 |
Why?
|
| Body Height | 1 | 1972 | 1579 | 0.000 |
Why?
|
| Heart Valve Diseases | 1 | 1972 | 1073 | 0.000 |
Why?
|
| Mitral Valve | 1 | 1972 | 1491 | 0.000 |
Why?
|
| Aortic Valve | 1 | 1972 | 1920 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1972 | 2267 | 0.000 |
Why?
|
| Body Weight | 1 | 1972 | 4670 | 0.000 |
Why?
|
| Heart Failure | 1 | 1972 | 10896 | 0.000 |
Why?
|